Connect with us

Business

What’s going on with the Mesoblast (ASX:MSB) share price in 2020?

Published

on

The Mesoblast limited (ASX: MSB) share price has had an incredibly eventful year.

The stem cell-focused biotech company’s shares have been as high as $5.70 and as low as $1.02.

Today, the Mesoblast share price sits at $2.40 after crashing over 40% lower last week.

What is happening with the Mesoblast share price?

Mesoblast has been extremely busy this year with a number of key trials and applications.

This includes running a trial for remestemcel-L in the treatment of COVID-19 Acute Respiratory Distress Syndrome (ARDS), an application for remestemcel-L to treat paediatric patients with steroid-refractory acute graft versus host disease (SR-aGvHD), and a trial of rexlemestrocel-L in patients with advanced chronic heart…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending